What is Abridge?
Abridge offers a sophisticated solution for managing health-related conversations. By recording and transcribing medical appointments, whether in-person or via telemedicine, the platform generates interactive summaries that pinpoint crucial medical information. This technology aims to bridge the communication gap between patients, their families, and clinicians, fostering greater understanding and ensuring better follow-through on treatment plans. The company's focus on clarity and accessibility in healthcare communication positions it as a key player in the digital health sector.
How much funding has Abridge raised?
Abridge has raised a total of $757.5M across 6 funding rounds:
Other Financing Round
$15M
Series A
$12.5M
Series B
$30M
Series C
$150M
Series D
$250M
Series E
$300M
Other Financing Round (2020): $15M with participation from University of Pittsburgh Medical Center, Union Square Ventures, Bessemer Venture Partners, Pillar, and KdT Ventures
Series A (2022): $12.5M led by Union Square Ventures, Bessemer Venture Partners, and Wittington Ventures
Series B (2023): $30M supported by Spark Capital, Bessemer Venture Partners, Uc Investments, Scan Group, LifePoint Health, and Mayo Clinic
Series C (2024): $150M featuring Redpoint Ventures, Union Square Ventures, Bessemer Venture Partners, Wittington Ventures, Mass General Brigham, Lightspeed Venture Partners, Kaiser Permanente, and CVS Health
Series D (2025): $250M backed by Elad Gil, Lightspeed Venture Partners, CapitalG, Bessemer Venture Partners, IVP, CVS Health, and California Health Care Foundation
Series E (2025): $300M with participation from Lightspeed Venture Partners, CVS Health, and Andreessen Horowitz
Key Investors in Abridge
Lightspeed Venture Partners
Lightspeed Venture Partners is a global multistage venture capital firm that invests in early and growth-stage technology companies across various sectors, partnering with founders from seed through IPO/M&A.
CVS Health
CVS Health is building a world of health around every consumer, delivering high-quality, affordable health care when and how individuals choose, with a mission to improve health and well-being.
Bessemer Venture Partners
Bessemer Venture Partners is a venture capital firm with a long history, investing in innovative companies across various sectors and stages, providing capital and strategic guidance to founders.
What's next for Abridge?
With substantial backing from prominent investors, Abridge is poised for accelerated growth and further innovation. The recent major strategic investment suggests a focus on scaling operations, expanding its technological capabilities, and potentially forging deeper partnerships within the healthcare ecosystem. Future developments are likely to center on enhancing AI-driven insights, broadening the platform's integration with existing healthcare systems, and solidifying its market leadership in making medical information more accessible and actionable for all stakeholders.
See full Abridge company page
